Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
We learned that more imaging, more biomarkers or longer evaluations dont improve outcomes unless they: reclassify risk alter timing or intensity of intervention or meaningfully change trajectory on follow-up Longevity medicine is now at that same inflection point
Its a common question, and the answer can sometimes be complicated
A single low B12 result rarely points to cancer by itself, but persistent deficiency combined with worsening health changes deserves medical attention
We loved having you
US$ 25.28
US$ 29.44
US$ 26.21
